Henrik Bjarke Vaegter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Henrik Bjarke Vaegter has a total of 295 co-authors. Here are the top co-authors by number of shared publications:
- Karin Due Bruun
Pain Research Group, Pain Center Odense University Hospital Odense Denmark
11 shared publications Gitte Handberg
Pain Research Group , Pain Center Odense, Denmark
10 shared publications- Thomas Graven-Nielsen
Center for Neuroplasticity and Pain (CNAP), Department of Health Science and Technology, Faculty of Medicine Aalborg University Aalborg Denmark
10 shared publications - Jonas Bloch Thorlund
Center for Muscle and Joint Health, Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark
7 shared publications - Sophie Lykkegaard Ravn
Department of Psychology, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark
7 shared publications - Morten Rune Blichfeldt-Eckhardt
Department of Regional Health Research, University of Southern Denmark, Odense, Denmark
6 shared publications
Latest Publications
- Open Access
- 5 November 2026
- Published by Wiley in Journal of Sleep Research
Temporal Associations Between Physiological Sleep and Next‐Day Pain Intensity in Individuals With Activity‐Limiting Chronic Pain: A Multiple Night At‐Home Ear‐ EEG Sleep‐Monitoring Study
Chronic pain and sleep disturbances frequently co‐occur. However, most prior research relies on self‐report or actigraphy, which reflect behavioural aspects of sleep but provide only limited insight into the underlying sleep physiology. In this pre‐registered prospective observational study (NCT06368531), we investigated within‐person night‐to‐night variability in physiological sleep metrics and explored temporal associations between sleep metrics and next‐day pain. Individuals with bothersome ( n = 4) or high‐impact ( n = 15) chronic pain completed between 11 and 33 nights of at‐home sleep monitoring using an ear‐EEG device and rated morning pain intensity daily on a 0–10 numerical rating scale. This design enables assessment of real‐world physiological sleep patterns alongside natural fluctuations in pain, offering a high‐resolution view of sleep–pain dynamics beyond traditional diary or actigraphy‐based methods. Substantial between‐night variability was observed across multiple sleep metrics, such as sleep efficiency and sleep stage transitions (ICC values < 0.5), indicating that less than half of the total variance was attributable to differences between subjects, underscoring the importance of longitudinal within‐person monitoring. Mixed‐effects model analyses revealed that lower next‐day pain intensity was associated with greater duration ( β = −0.01, p = 0.005), higher percentage ( β = −0.07, p = 0.001) and increased stability ( β = −0.01, p = 0.013) of N3 sleep. In contrast, higher next‐day pain was associated with increased N3 fragmentation ( β = 0.01, p = 0.014) and a higher proportion of N1 sleep ( β = 0.014, p = 0.007). Together, these findings provide objective physiological support for previously reported associations between sleep and pain, highlighting the value of longitudinal ear‐EEG monitoring for capturing nightly sleep–pain dynamics. Trial Registration: ClinicalTrials.gov identifier: NCT06368531.
- 5 November 2026
- Published by Wiley in Journal of Sleep Research
Open AccessTemporal Associations Between Physiological Sleep and Next‐Day Pain Intensity in Individuals With Activity‐Limiting Chronic Pain: A Multiple Night At‐Home Ear‐ EEG Sleep‐Monitoring Study
Chronic pain and sleep disturbances frequently co‐occur. However, most prior research relies on self‐report or actigraphy, which reflect behavioural aspects of sleep but provide only limited insight into the underlying sleep physiology. In this pre‐registered prospective observational study (NCT06368531), we investigated within‐person night‐to‐night variability in physiological sleep metrics and explored temporal associations between sleep metrics and next‐day pain. Individuals with bothersome ( n = 4) or high‐impact ( n = 15) chronic pain completed between 11 and 33 nights of at‐home sleep monitoring using an ear‐EEG device and rated morning pain intensity daily on a 0–10 numerical rating scale. This design enables assessment of real‐world physiological sleep patterns alongside natural fluctuations in pain, offering a high‐resolution view of sleep–pain dynamics beyond traditional diary or actigraphy‐based methods. Substantial between‐night variability was observed across multiple sleep metrics, such as sleep efficiency and sleep stage transitions (ICC values < 0.5), indicating that less than half of the total variance was attributable to differences between subjects, underscoring the importance of longitudinal within‐person monitoring. Mixed‐effects model analyses revealed that lower next‐day pain intensity was associated with greater duration ( β = −0.01, p = 0.005), higher percentage ( β = −0.07, p = 0.001) and increased stability ( β = −0.01, p = 0.013) of N3 sleep. In contrast, higher next‐day pain was associated with increased N3 fragmentation ( β = 0.01, p = 0.014) and a higher proportion of N1 sleep ( β = 0.014, p = 0.007). Together, these findings provide objective physiological support for previously reported associations between sleep and pain, highlighting the value of longitudinal ear‐EEG monitoring for capturing nightly sleep–pain dynamics. Trial Registration: ClinicalTrials.gov identifier: NCT06368531.
- Open Access
- 6 October 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (10) , 1062
Correction to: Identification of high-impact chronic pain among cancer survivors: a cross-sectional study using the Graded Chronic Pain Scale framework
- 6 October 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (10) , 1062
Open AccessCorrection to: Identification of high-impact chronic pain among cancer survivors: a cross-sectional study using the Graded Chronic Pain Scale framework
- 24 September 2026
- Published by Wiley in European journal of pain
- Vol. 30 (9) , e70398
Walking for Chronic Pain: Why It Matters, What We Know and How to Get Started: A Position Paper From the European Pain Federation ( EFIC ) ‘On The Move’ Task Force
Background: Physical activity is a cornerstone of chronic pain management. However, translating general recommendations into practical, clinically meaningful guidance for people living with chronic pain and their healthcare providers remains challenging. Walking represents a promising modality because it is accessible, adaptable, low‐cost and easily integrated into daily life. Objective: This position paper synthesises evidence on walking as a therapeutic modality for people living with chronic pain, identifies key knowledge gaps and provides a guiding message for healthcare professionals to support clinical communication and patient self‐management. Methods: Narrative synthesis of scientific literature examining walking interventions in chronic musculoskeletal pain conditions. Evidence regarding step counts, progression strategies and behavioural factors influencing engagement in walking was integrated to inform clinically applicable recommendations. Results: Walking interventions demonstrate small‐to‐moderate improvements in pain, physical function and health‐related quality of life. Benefits of walking occur at activity levels below traditional public‐health targets, with the largest gains observed when individuals transition from very low to moderate activity levels. Current research does not support universal step‐count targets for pain reduction, emphasising instead individualised progression and consistency. Available evidence shows no association between walking participation and worsening pain severity at the population level. Gradual engagement in walking may also provide opportunities to build confidence in one's ability to be physically active. However, walking interventions are frequently delivered alongside education, goal setting, activity monitoring or healthcare professional support, making it difficult to determine the independent contribution of walking to changes in beliefs about movement and activity. Conclusions: Walking is a generally safe, scalable, evidence‐supported strategy for chronic pain management. Rather than fixed targets, gradual progression tailored to individual capacity represents the most evidence‐aligned strategy. This paper provides a guiding message to facilitate implementation of walking and physical activity recommendations in routine care. Significance Statement: This paper translates current evidence on walking and chronic pain into clinically applicable guidance for healthcare professionals and people living with chronic pain. Building on previous EFIC recommendations regarding physical activity, it synthesises evidence across chronic musculoskeletal pain conditions, addresses common barriers such as fear of movement and symptom flare‐ups, and provides evidence‐informed practical recommendations to support safe, gradual and sustainable walking participation in routine care and self‐management.
- 24 September 2026
- Published by Wiley in European journal of pain
- Vol. 30 (9) , e70398
Walking for Chronic Pain: Why It Matters, What We Know and How to Get Started: A Position Paper From the European Pain Federation ( EFIC ) ‘On The Move’ Task Force
Background: Physical activity is a cornerstone of chronic pain management. However, translating general recommendations into practical, clinically meaningful guidance for people living with chronic pain and their healthcare providers remains challenging. Walking represents a promising modality because it is accessible, adaptable, low‐cost and easily integrated into daily life. Objective: This position paper synthesises evidence on walking as a therapeutic modality for people living with chronic pain, identifies key knowledge gaps and provides a guiding message for healthcare professionals to support clinical communication and patient self‐management. Methods: Narrative synthesis of scientific literature examining walking interventions in chronic musculoskeletal pain conditions. Evidence regarding step counts, progression strategies and behavioural factors influencing engagement in walking was integrated to inform clinically applicable recommendations. Results: Walking interventions demonstrate small‐to‐moderate improvements in pain, physical function and health‐related quality of life. Benefits of walking occur at activity levels below traditional public‐health targets, with the largest gains observed when individuals transition from very low to moderate activity levels. Current research does not support universal step‐count targets for pain reduction, emphasising instead individualised progression and consistency. Available evidence shows no association between walking participation and worsening pain severity at the population level. Gradual engagement in walking may also provide opportunities to build confidence in one's ability to be physically active. However, walking interventions are frequently delivered alongside education, goal setting, activity monitoring or healthcare professional support, making it difficult to determine the independent contribution of walking to changes in beliefs about movement and activity. Conclusions: Walking is a generally safe, scalable, evidence‐supported strategy for chronic pain management. Rather than fixed targets, gradual progression tailored to individual capacity represents the most evidence‐aligned strategy. This paper provides a guiding message to facilitate implementation of walking and physical activity recommendations in routine care. Significance Statement: This paper translates current evidence on walking and chronic pain into clinically applicable guidance for healthcare professionals and people living with chronic pain. Building on previous EFIC recommendations regarding physical activity, it synthesises evidence across chronic musculoskeletal pain conditions, addresses common barriers such as fear of movement and symptom flare‐ups, and provides evidence‐informed practical recommendations to support safe, gradual and sustainable walking participation in routine care and self‐management.
- Open Access
- 11 September 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (10) , 961
Identification of high-impact chronic pain among cancer survivors: a cross-sectional study using the Graded Chronic Pain Scale framework
Purpose: Chronic cancer-related pain is a prevalent and often under-recognized issue among individuals living with or after cancer. Clinically useful tools are needed to classify pain severity and impact and to identify those requiring targeted support. This study applied the Graded Chronic Pain Scale–Revised (GCPS-R) in a cohort of cancer survivors and examined differences in pain characteristics and psychosocial factors across GCPS-R subgroups. Secondly, the study compared pain characteristics in cancer survivors with high-impact chronic pain (HICP) to an age- and sex-matched sample of patients with non-cancer HICP. Methods: Patients attending a residential cancer rehabilitation course completed a screening questionnaire and a pain-specific module including the GCPS-R and validated measures of disability, psychological distress, pain catastrophizing, and self-rated health. Cancer survivors with HICP were matched 1:3 to patients with non-cancer HICP using registry data collected prior to their initial consultation at an interdisciplinary Pain Center. Results: Among 270 cancer survivors included in the analysis, 61% were classified as having HICP. Increasing GCPS-R impact levels were associated with greater pain intensity and disability, higher psychological distress and pain catastrophizing, and poorer self-rated health and quality of life ( p < 0.05). Compared with matched non-cancer patients with HICP, cancer survivors reported lower pain intensity and catastrophizing but were at least as likely to meet criteria for widespread pain. Conclusion: HICP is present among cancer survivors seeking rehabilitation. The GCPS-R can differentiate clinically meaningful subgroups and may support systematic assessment of pain severity and impact to identify patients requiring targeted support.
- 11 September 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (10) , 961
Open AccessIdentification of high-impact chronic pain among cancer survivors: a cross-sectional study using the Graded Chronic Pain Scale framework
Purpose: Chronic cancer-related pain is a prevalent and often under-recognized issue among individuals living with or after cancer. Clinically useful tools are needed to classify pain severity and impact and to identify those requiring targeted support. This study applied the Graded Chronic Pain Scale–Revised (GCPS-R) in a cohort of cancer survivors and examined differences in pain characteristics and psychosocial factors across GCPS-R subgroups. Secondly, the study compared pain characteristics in cancer survivors with high-impact chronic pain (HICP) to an age- and sex-matched sample of patients with non-cancer HICP. Methods: Patients attending a residential cancer rehabilitation course completed a screening questionnaire and a pain-specific module including the GCPS-R and validated measures of disability, psychological distress, pain catastrophizing, and self-rated health. Cancer survivors with HICP were matched 1:3 to patients with non-cancer HICP using registry data collected prior to their initial consultation at an interdisciplinary Pain Center. Results: Among 270 cancer survivors included in the analysis, 61% were classified as having HICP. Increasing GCPS-R impact levels were associated with greater pain intensity and disability, higher psychological distress and pain catastrophizing, and poorer self-rated health and quality of life ( p < 0.05). Compared with matched non-cancer patients with HICP, cancer survivors reported lower pain intensity and catastrophizing but were at least as likely to meet criteria for widespread pain. Conclusion: HICP is present among cancer survivors seeking rehabilitation. The GCPS-R can differentiate clinically meaningful subgroups and may support systematic assessment of pain severity and impact to identify patients requiring targeted support.
- Open Access
- 20 April 2026
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 195, 112287
Responsiveness and minimal important change thresholds of PROMIS-10 Global Health in patients with chronic pain treated at interdisciplinary pain centers
- 20 April 2026
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 195, 112287
Open AccessResponsiveness and minimal important change thresholds of PROMIS-10 Global Health in patients with chronic pain treated at interdisciplinary pain centers
- Open Access
- 1 February 2026
- Published by Springer Nature in Quality of Life Research
- Vol. 35 (3) , 53
Patients’ interpretations of individual PROMIS-10 Global Health items: a cognitive interview study in high-impact chronic pain
Purpose: The purpose of this study was to explore the content validity of the Danish version of the PROMIS-10 Global Health questionnaire in patients with high-impact chronic pain by (1) identifying problematic items and reasons for misunderstandings between participants’ interpretations and the intended meaning, and (2) exploring how participants understand and interpret the items. Methods: Individual cognitive interviews were conducted with participants with high-impact chronic pain referred to two Danish Pain Centers using a structured step-by-step interview approach. The first objective was analyzed mainly using a deductive structured approach, while the second objective was analyzed mainly using an inductive thematic approach focusing on participants’ perspectives. Results: Participants (n = 19) generally understood the items as intended but showed 21% and 11% non-congruency for items 8r (fatigue) and 7r (pain intensity), as they responded based on a longer timeframe than “the past 7 days”. Overall, participants interpreted the items through a physical, psychological and social perspective. Further, items 5 (social activities and relationships) and 6 (daily physical activities) were perceived to overlap thematically with item 9r (social activities and roles). Additionally, the provided examples in items 5 and 6 influenced responses, and some deemed item 7r irrelevant, as it did not reflect their pain experiences. Conclusion: The findings contribute to the validation of PROMIS-10 Global Health in patients with high-impact chronic pain by providing insights into how participants understand and interpret the items, highlighting areas for minor refinement. Further qualitative research on the validity of PROMIS-10 Global Health in this population is needed.
- 1 February 2026
- Published by Springer Nature in Quality of Life Research
- Vol. 35 (3) , 53
Open AccessPatients’ interpretations of individual PROMIS-10 Global Health items: a cognitive interview study in high-impact chronic pain
Purpose: The purpose of this study was to explore the content validity of the Danish version of the PROMIS-10 Global Health questionnaire in patients with high-impact chronic pain by (1) identifying problematic items and reasons for misunderstandings between participants’ interpretations and the intended meaning, and (2) exploring how participants understand and interpret the items. Methods: Individual cognitive interviews were conducted with participants with high-impact chronic pain referred to two Danish Pain Centers using a structured step-by-step interview approach. The first objective was analyzed mainly using a deductive structured approach, while the second objective was analyzed mainly using an inductive thematic approach focusing on participants’ perspectives. Results: Participants (n = 19) generally understood the items as intended but showed 21% and 11% non-congruency for items 8r (fatigue) and 7r (pain intensity), as they responded based on a longer timeframe than “the past 7 days”. Overall, participants interpreted the items through a physical, psychological and social perspective. Further, items 5 (social activities and relationships) and 6 (daily physical activities) were perceived to overlap thematically with item 9r (social activities and roles). Additionally, the provided examples in items 5 and 6 influenced responses, and some deemed item 7r irrelevant, as it did not reflect their pain experiences. Conclusion: The findings contribute to the validation of PROMIS-10 Global Health in patients with high-impact chronic pain by providing insights into how participants understand and interpret the items, highlighting areas for minor refinement. Further qualitative research on the validity of PROMIS-10 Global Health in this population is needed.
- Open Access
- 22 January 2026
- Published by Springer Nature in Quality of Life Research
- Vol. 35 (2) , 50
What constitutes important change in individual PROMIS-10 global health items in patients with high-impact chronic pain: a qualitative interview study
Purpose: Health-related quality of life is a key outcome for patients with high-impact chronic pain, and the PROMIS-10 Global Health questionnaire is widely used to assess it. This study examined what patients perceive as important changes in PROMIS-10 Global Health items by 1) 1) examining how much each item should change to be perceived as important, and 2) exploring why and how these changes were considered important. Methods: Individual semi-structured interviews with 17 participants with high-impact chronic pain were conducted. Analysis for objective one involved determining item-level thresholds for important change by aggregating participants’ reported change scores for each item. Analysis for objective two involved thematic analysis to explore how and why such changes were perceived as important. Results: For items rated on a 5-point Likert scale, change scores perceived as important ranged from a mean of 1.09 (median = 1) for item 1 (general health) to a mean of 1.84 (median = 2) for item 8r (fatigue). For item 7r (pain intensity), rated on a 0–10 scale, a mean change score of 4.36 (median = 4.25) was considered important. Thematic analysis identified one to two themes per item, reflecting perceived important improvement across physical, mental, and social health. Conclusion: This is the first qualitative study to explore what patients with high-impact chronic pain perceive as important changes in PROMIS-10 Global Health items. Findings reflect important improvements across physical, mental, and social health, highlighting the value of patient perspectives in clinical use. Further qualitative research is needed to enhance interpretation and inform clinical applications.
- 22 January 2026
- Published by Springer Nature in Quality of Life Research
- Vol. 35 (2) , 50
Open AccessWhat constitutes important change in individual PROMIS-10 global health items in patients with high-impact chronic pain: a qualitative interview study
Purpose: Health-related quality of life is a key outcome for patients with high-impact chronic pain, and the PROMIS-10 Global Health questionnaire is widely used to assess it. This study examined what patients perceive as important changes in PROMIS-10 Global Health items by 1) 1) examining how much each item should change to be perceived as important, and 2) exploring why and how these changes were considered important. Methods: Individual semi-structured interviews with 17 participants with high-impact chronic pain were conducted. Analysis for objective one involved determining item-level thresholds for important change by aggregating participants’ reported change scores for each item. Analysis for objective two involved thematic analysis to explore how and why such changes were perceived as important. Results: For items rated on a 5-point Likert scale, change scores perceived as important ranged from a mean of 1.09 (median = 1) for item 1 (general health) to a mean of 1.84 (median = 2) for item 8r (fatigue). For item 7r (pain intensity), rated on a 0–10 scale, a mean change score of 4.36 (median = 4.25) was considered important. Thematic analysis identified one to two themes per item, reflecting perceived important improvement across physical, mental, and social health. Conclusion: This is the first qualitative study to explore what patients with high-impact chronic pain perceive as important changes in PROMIS-10 Global Health items. Findings reflect important improvements across physical, mental, and social health, highlighting the value of patient perspectives in clinical use. Further qualitative research is needed to enhance interpretation and inform clinical applications.
- Open Access
- 1 January 2026
- Published by Walter de Gruyter GmbH in Scandinavian Journal of Pain
- Vol. 26 (1)
Assessment, diagnosis, and treatment of patients with high-impact chronic pain – guideline adherence in five specialized multidisciplinary pain centers in Denmark
Objectives: The audit explores adherence to the Danish Health Authorities’ recommendations of assessment, diagnosis, and treatment domains in five tertiary multidisciplinary pain centers in three of five regions in Denmark. Methods: We conducted a systematic clinical audit of medical records from 100 patients with high-impact chronic pain (HICP), sampling 20 records at each center. A structured checklist, based on national guidelines, examined the documentation prevalence across bio-psycho-social issues, pain mechanism identification, and treatment, including non-pharmacological and pharmacological interventions, and discharge planning. Guideline adherence and inter-center variations were examined. Data are presented as median (IQR). Results: The patient age was 51 (42–59) years, and 63 % were females. The median treatment duration was 35 (17–50) weeks, with 14 (6–23) healthcare contacts involving 3.1 (2.7–4.0) healthcare professions per patient. Documentation of the target issues in the medical records was as follows: physical examination 37 % (1–17/center), psychological factors 65 % (5–20/center), socio-economic factors 98 % (19–20/center), pain mechanisms 66 % (3–17/center), non-pharmacological treatments 89 % (14–20/center), group treatment 57 % (3–17/center), analgesic consumption at referral 96 % and at discharge 83 %, add-on pharmacological treatments 69 % (8–18/center), opioid use at referral 38 % (4–11/center), and weaning off during treatment 18 % (2–6/center), non-evidence-based pharmacological treatments 21 % (0–12/center), prospective treatment plans in discharge reports 14 % (2–4/center), and overall assessment of patients’ satisfaction with treatment outcomes 40 % (3–11/center). Conclusions: While socio-economic and psychological assessments, and multidisciplinary, non-pharmacological treatments seemed adequately documented, a wide inter-center variation in the documentation of physical examination, diagnostic, pharmacological, and discharge procedures was observed. Standardizing documentation practices is essential to improve consistency and quality of care in Danish multidisciplinary pain centers.
- 1 January 2026
- Published by Walter de Gruyter GmbH in Scandinavian Journal of Pain
- Vol. 26 (1)
Open AccessAssessment, diagnosis, and treatment of patients with high-impact chronic pain – guideline adherence in five specialized multidisciplinary pain centers in Denmark
Objectives: The audit explores adherence to the Danish Health Authorities’ recommendations of assessment, diagnosis, and treatment domains in five tertiary multidisciplinary pain centers in three of five regions in Denmark. Methods: We conducted a systematic clinical audit of medical records from 100 patients with high-impact chronic pain (HICP), sampling 20 records at each center. A structured checklist, based on national guidelines, examined the documentation prevalence across bio-psycho-social issues, pain mechanism identification, and treatment, including non-pharmacological and pharmacological interventions, and discharge planning. Guideline adherence and inter-center variations were examined. Data are presented as median (IQR). Results: The patient age was 51 (42–59) years, and 63 % were females. The median treatment duration was 35 (17–50) weeks, with 14 (6–23) healthcare contacts involving 3.1 (2.7–4.0) healthcare professions per patient. Documentation of the target issues in the medical records was as follows: physical examination 37 % (1–17/center), psychological factors 65 % (5–20/center), socio-economic factors 98 % (19–20/center), pain mechanisms 66 % (3–17/center), non-pharmacological treatments 89 % (14–20/center), group treatment 57 % (3–17/center), analgesic consumption at referral 96 % and at discharge 83 %, add-on pharmacological treatments 69 % (8–18/center), opioid use at referral 38 % (4–11/center), and weaning off during treatment 18 % (2–6/center), non-evidence-based pharmacological treatments 21 % (0–12/center), prospective treatment plans in discharge reports 14 % (2–4/center), and overall assessment of patients’ satisfaction with treatment outcomes 40 % (3–11/center). Conclusions: While socio-economic and psychological assessments, and multidisciplinary, non-pharmacological treatments seemed adequately documented, a wide inter-center variation in the documentation of physical examination, diagnostic, pharmacological, and discharge procedures was observed. Standardizing documentation practices is essential to improve consistency and quality of care in Danish multidisciplinary pain centers.
- Open Access
- 1 January 2026
- Published by Korean Pain Society in The Korean Journal of Pain
- Vol. 39 (1) , 140-143
Low-dose naltrexone for fibromyalgia: a re-analysis suggests lower efficacy than previously reported
Karin Due Bruun, Maria Juul Nielsen, Henrik Bjarke Vaegter, Morten Rune Blichfeldt-Eckhardt, Kirstine Amris, and Julie Roenne Pedersen. Korean J Pain 2026;39:140-3. https://doi.org/10.3344/kjp.25275
- 1 January 2026
- Published by Korean Pain Society in The Korean Journal of Pain
- Vol. 39 (1) , 140-143
Open AccessLow-dose naltrexone for fibromyalgia: a re-analysis suggests lower efficacy than previously reported
Karin Due Bruun, Maria Juul Nielsen, Henrik Bjarke Vaegter, Morten Rune Blichfeldt-Eckhardt, Kirstine Amris, and Julie Roenne Pedersen. Korean J Pain 2026;39:140-3. https://doi.org/10.3344/kjp.25275
- 5 December 2025
- Published by Wolters Kluwer Health in JBI Evidence Synthesis
- Vol. 23 (12) , 2497-2505
Short-term effects of preparatory suggestions on pain in adults undergoing nonpharmacological treatments: a systematic review protocol
Introduction: Clinicians often prepare patients for a treatment by suggesting that their pain levels are likely to reduce or increase during or shortly after the treatment, thereby potentially creating expectations about pain. Several randomized controlled trials have investigated the short-term effects of preparatory suggestions on pain in adults undergoing nonpharmacological treatments, but their findings are inconsistent. Objective: We will conduct a systematic review to explore whether positive and negative preparatory suggestions reduce and increase pain, respectively, in adults during and shortly after nonpharmacological treatments compared to no or neutral preparatory suggestions, and if so, to what extent. Eligibility criteria: The review will include randomized controlled trials in which the participants are adults undergoing a nonpharmacological treatment. The intervention group must receive positive or negative preparatory suggestions, while the comparator group must receive no or neutral preparatory suggestions. The outcomes must be within the category of pain and assessed numerically during or shortly after the treatment. Methods: The review will be conducted in line with the JBI methodology for systematic reviews of effectiveness. Studies were identified by searching in Embase (Ovid), MEDLINE (Ovid), PsycINFO (Ovid), Cochrane CENTRAL, and Google Scholar. Two reviewers will independently screen the identified studies, extract data, and evaluate the methodological quality and certainty in the findings. In addition, a narrative synthesis and meta-analyses will be performed. Effect sizes for continuous and binary outcomes will be computed as standardized mean differences and relative risks, respectively. A restricted maximum likelihood mixed effects model will be applied in the meta-analyses. Review registration: PROSPERO CRD42024587230
- 5 December 2025
- Published by Wolters Kluwer Health in JBI Evidence Synthesis
- Vol. 23 (12) , 2497-2505
Short-term effects of preparatory suggestions on pain in adults undergoing nonpharmacological treatments: a systematic review protocol
Introduction: Clinicians often prepare patients for a treatment by suggesting that their pain levels are likely to reduce or increase during or shortly after the treatment, thereby potentially creating expectations about pain. Several randomized controlled trials have investigated the short-term effects of preparatory suggestions on pain in adults undergoing nonpharmacological treatments, but their findings are inconsistent. Objective: We will conduct a systematic review to explore whether positive and negative preparatory suggestions reduce and increase pain, respectively, in adults during and shortly after nonpharmacological treatments compared to no or neutral preparatory suggestions, and if so, to what extent. Eligibility criteria: The review will include randomized controlled trials in which the participants are adults undergoing a nonpharmacological treatment. The intervention group must receive positive or negative preparatory suggestions, while the comparator group must receive no or neutral preparatory suggestions. The outcomes must be within the category of pain and assessed numerically during or shortly after the treatment. Methods: The review will be conducted in line with the JBI methodology for systematic reviews of effectiveness. Studies were identified by searching in Embase (Ovid), MEDLINE (Ovid), PsycINFO (Ovid), Cochrane CENTRAL, and Google Scholar. Two reviewers will independently screen the identified studies, extract data, and evaluate the methodological quality and certainty in the findings. In addition, a narrative synthesis and meta-analyses will be performed. Effect sizes for continuous and binary outcomes will be computed as standardized mean differences and relative risks, respectively. A restricted maximum likelihood mixed effects model will be applied in the meta-analyses. Review registration: PROSPERO CRD42024587230